SCHEMBL6323161

SCHEMBL6323161

Cc1ccc(-c2noc(N)c2C(=O)NC2CCc3ccccc32)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
HSD17B10 Q99714 2/20 0.52
RECQL P46063 1/20 0.52
TSHR P16473 1/20 0.50
TAS1R3 Q7RTX0 5/20 0.47
TAS1R1 Q7RTX1 5/20 0.47
TAS1R2 Q8TE23 5/20 0.47
PDE2A O00408 1/20 0.44
MLLT3 P42568 1/20 0.43
MLLT1 Q03111 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ADORA2A P29274 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317860 0.94 ALDH1A1 (0.60) ALDH1A1HSD17B10RECQLTSHRTAS1R3
SCHEMBL6323374 0.88 CA1 (0.49) ALDH1A1RECQLTSHRTAS1R3TAS1R1
SCHEMBL6319067 0.84 RECQL (0.51) ALDH1A1HSD17B10RECQLTSHRTAS1R3
SCHEMBL6315372 0.83 TAS1R3 (0.46) RECQLTSHRTAS1R3TAS1R1TAS1R2
SCHEMBL6322801 0.83 TAS1R3 (0.55) ALDH1A1HSD17B10RECQLTSHRTAS1R3
SCHEMBL6323197 0.82 TAS1R3 (0.52) ALDH1A1HSD17B10RECQLTSHRTAS1R3
SCHEMBL6316840 0.81 RECQL (0.49) ALDH1A1RECQLTSHRTAS1R3TAS1R1
SCHEMBL6321850 0.81 RECQL (0.50) ALDH1A1HSD17B10RECQLTSHRTAS1R3
SCHEMBL6317913 0.81 MLLT3 (0.41) ALDH1A1RECQLTSHRTAS1R3TAS1R1
SCHEMBL6315002 0.80 RECQL (0.47) ALDH1A1HSD17B10RECQLTSHRTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
CN-1549714-A Aminoisoxazole derivatives active as kinase inhibitors 2004-11-24 CN claimed
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 ALDH1A1 4444/4885HSD17B10 4152/4885RECQL 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.